GOOG 1-day forecast by Grok 4

Grok 4's 1-day forecast for GOOG, made 2026-09-23: expected range $330.00 to $342.00 at 43% confidence. Settled at $337.46: direction called correctly, score 78.9.

AssetGOOG
ModelGrok 4
Recorded byForecastnest
Forecast made
Horizon1-day (Equity / ETF 1D: the stored target below is authoritative; it may be a session close or an intraday instant.)
Window closes
Price when asked$335.63
Price the model reported$335.50
Expected range$330.00 to $342.00
Confidence43%
Prompt styleNo data
StatusSettled
Actual close$337.46
Traded range in the window$333.41 to $338.94
ResultDirection called correctly
Score78.9 of 100

The model's reasoning

(1) What you found, and where: Live quotes from StockAnalysis ($335.57 as of 3:05 p.m. EDT), TradeSmith ($336.04 around 2:49 p.m.), MarketWatch and others show GOOG trading near $334.70-$336.00 in the afternoon of September 23, 2026. Previous close was $347.41. Day range has been approximately $334.20-$346.33 on elevated volume.

(2) The current market regime as you read it: Sharp downside session driven by investor sensitivity to elevated AI-related capital expenditures and free-cash-flow pressure, even as underlying business metrics (cloud growth, advertising resilience) remain constructive. The stock has pulled back from recent levels near $350-$360 while still holding well above its 52-week low. Broader tech and semiconductor weakness has amplified the move.

(3) Price range justification, with the levels and volatility you are using: Anchored to the ~$335.50 quote, the $330-$342 range reflects today’s realized volatility and typical one-day swings for GOOG (recent daily ranges of several dollars). Support aligns with the session low and prior consolidation zones near $330-$334; resistance sits near the midpoint of today’s range and prior-close proximity around $342. The range is modestly asymmetric lower to account for possible follow-through selling after a large down day.

(4) Scheduled or likely catalysts inside the window: No major corporate earnings or product events in the immediate 24-hour period. Residual focus on any further commentary around AI infrastructure spending, regulatory headlines (search choice screens, privacy), or broader mega-cap tech flows. Next formal earnings are further out (late October).

(5) The strongest counter-argument, and what would invalidate your call: A swift bounce on bargain-hunting or positive AI product updates could recover toward or above $342. Continued risk-off sentiment or renewed focus on capex intensity could drive a test of $330 or lower. A decisive close outside the stated range on volume would invalidate the near-term mild-bearish lean.

(6) Why your confidence is the number it is: One-day direction after a multi-percent gap-down session is frequently noisy for large-cap tech names. Live price and session data provide a clear anchor, but the mix of strong longer-term fundamentals, elevated short-term volatility, and absence of an immediate catalyst keeps conviction in the low-to-mid 40s percent range.

Other models on the same question

ModelExpected rangeConfidenceResultScore
GPT-5.6 Sol$326.00 to $346.5063%No directional call52.8
Claude Opus 5$338.00 to $353.0022%Direction called incorrectly3.7
Muse Spark 1.1$330.00 to $342.0058%Direction called correctly80.4
Gemini 1.5 Pro$330.00 to $342.0070%Direction called correctly81.6
DeepSeek$332.00 to $348.0055%Direction called correctly74.4

How this forecast is measured

Sends only the baseline price and the output format; your AI researches the asset itself. Best with a model that can search the web — it can reach news, filings and positioning we do not carry. Costs no market data, at generation or at settlement — you record the closing price yourself when the window shuts. The monthly allowance is what a membership buys, not a data bill.

Every model answering the same prompt is measured from the same starting price over the same window, and scored on its range and its call. How scoring works · All shared research.

ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.